Liang et al. (2009) found that RGS16 overexpression in breast cancer cell lines decreased EGF induced proliferation and AKT activation by binding to the p85-alpha subunit of PI3K preventing the phosphorylation of AKT [19]. This evidence concerns the gene AKT1 and breast carcinoma.